NSFL1C Antibody [DyLight 350]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-36529UV
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse
Applications
Immunoprecipitation, Western Blot
Label
DyLight 350 (Excitation = 353 nm, Emission = 432 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
The immunogen recognized by the antibody maps to a region between residue 25 to 75 of human NSFL1 (p97) Cofactor (p47) using the numbering given in entry NP_057227.2.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for NSFL1C Antibody [DyLight 350]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: NSFL1C
Alternate Names
dJ776F14.1, NSFL1 (p97) cofactor (p47), NSFL1 cofactor p47, P47, p97 cofactor p47, SHP1 homolog, UBX domain protein 2C, UBX domain-containing protein 2C, UBX1, UBXD10, UBXN2CMGC3347
Gene Symbol
NSFL1C
Additional NSFL1C Products
Product Documents for NSFL1C Antibody [DyLight 350]
Product Specific Notices for NSFL1C Antibody [DyLight 350]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...